Even as Medtronic PLC and Medtronic Minimally Invasive Therapies progress toward becoming one company, each firm individually remains on the acquisition trail. Medtronic has announced two purchases in the past two days, and Covidien disclosed two in the past week to bulk up its vascular device business. The announcements come about two months after the companies announced an agreement for Medtronic to acquire Covidien for $42.9 billion. (See [A#01140623002].) [See Deal]
On Aug. 26, Medtronic announced a deal to bolster its market-leading position in the deep brain stimulation (DBS) market by adding Sapiens Steering Brain Stimulation GMBH, which is developing technology...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?